Date:
April 6,
2020
RemSleep
(RMSL) –
Eliminates Toxic Convertible Debt from its Balance
Sheet
RemSleep
Holdings (OTC
Pink: RMSL)
Elimination of
Toxic Debt from its balance sheet
Flagship
product DeltaWave now available for
pre order
RemSleep
Holdings (OTC
Pink: RMSL) has eliminated
the first two out of three convertible notes totaling almost
$250,000.00 from its balance sheet and
plans to have
the last eliminated from its prior to it becoming eligible for
conversion into the common stock which could be sold into the
market. Full
press release on
EmergingGrowth.com.
https://emerginggrowth.com/stock-report/?code=rmsl
Miami, FL --
InvestorsHub NewsWire -- April 6, 2020 -- EmergingGrowth.com,
a leading independent small cap media portal with an extensive
history of providing unparalleled content for the Emerging Growth
markets and companies, reports on Remsleep Holdings, Inc (OTC Pink:
RMSL)
This could be the
biggest play in the respiratory
space. See
the full story on
http://www.EmergingGrowth.com
RMSL
may not be at these levels much longer.
See the Press
Release and more on RemSleep Holdings, Inc. (OTC Pink:
RMSL) at
EmergingGrowth.com
https://emerginggrowth.com/stock-report/?code=rmsl
RemSleep
Holdings (OTC
Pink: RMSL), a medical
device manufacturer dedicated to forever changing the level of
treatment provided to obstructive sleep apnea
patents, the elimination of toxic
convertible debt from its balance sheet.
RemSleep
Holdings, Inc.
(OTC Pink: RMSL) has eliminated the first two out of three
convertible notes totaling almost $250,000.00 from its balance
sheet. The notes were scheduled to come due on April 15,
2020.
Remsleep
plans to have
the last of these notes eliminated from its balance sheet prior to
it becoming eligible for conversion into the common stock which
could be sold into the market.
In
October of 2019, RemSleep
Holdings sold
convertible debt in the form of three different notes to three
different investors to raise capital required to take its flagship
product, the DeltaWave
CPAP mask to
market. The notes were scheduled to come due on April 15,
2020, at which time, the debt holders would have had an option to
convert their debt into, up to, and potentially over a combined
14.7% of the outstanding shares of RemSleep
Holdings, Inc.
and sell those shares into the market without any
restriction.
Tom Wood, CEO
of RemSleep
Holdings, Inc.
commented, "We have always put the best interest of our
shareholders first and we are excited that we have the ability to
pay off these notes prior to any conversion that could ultimately
hurt the company's shareholders and its valuation."
RemSleep's
groundbreaking
DeltaWave
CPAP mask is
currently available for pre-order on the company's website.
(https://remsleep.com/product/deltawave/)
As
you can see by the daily chart, RemSleep Holdings (OTC Pink: RMSL) has been trading in a range
between .0055 and .008 for the past 8 trading
sessions.
The stock has had
a history of following up tight ranges with 200% plus
gains.
RMSL
may not be at these levels much longer.
See the Press
Release and more on RemSleep Holdings, Inc. (OTC Pink:
RMSL) at EmergingGrowth.com
https://emerginggrowth.com/stock-report/?code=rmsl
About
REMSleep
Holdiongs,
Inc.
https://remsleep.com
REMSleep
Holdings, Inc.
is a medical device manufacturer dedicated to forever changing the
level of treatment provided to obstructive sleep apnea patents. Our
focus is primarily designing and manufacturing devices and products
for the treatment of sleep apnea and other respiratory conditions.
With over 30 years of collective experience in CPAP therapy,
the REMSleep
team has
extensive knowledge and understanding of CPAP and the challenges of
patient compliance. We diligently strive for our products to make
the difference and improve the condition of those suffering from
sleep apnea.
REMSleep
Holdings, Inc.
has a new patent pending, innovative sleep apnea product that will
meet multiple market demand and be able to reach and address a
large percentage of the patient population who continue to struggle
with CPAP compliance.
Forward-looking Statements.
This press release may contain forward-looking statements regarding
Company. All statements, other than statements of historical fact
included herein, are "forward-looking statements" including
statements regarding the Company's future prospects and risks in
investing in Company's common stock. These statements are based
upon the Company's current expectations and speak only as of the
date hereof. Financial performance in one period does not
necessarily mean continued or better performance in the future. The
Company's actual results in
any endeavor may differ materially and adversely from those
expressed in any forward-looking statements as a result of various
factors and uncertainties, which factors or uncertainties may be
beyond our ability to foresee or control. Other risk factors
include the status of the Company's common stock as a "penny stock"
and those risk factors stated in reports filed with the U.S.
Securities and Exchange Commission or "SEC" on its EDGAR website
(URL: www.sec.gov).
About EmergingGrowth.com
EmergingGrowth.com is a leading independent
small cap media portal with an extensive history of providing
unparalleled content for the Emerging Growth markets and companies.
Through its evolution, EmergingGrowth.com found
a niche in identifying companies that can be overlooked by the
markets due to, among other reasons, trading price or market
capitalization. We look for strong management, innovation,
strategy, execution, and the overall potential for long- term
growth. Aside from being a trusted resource for the Emerging Growth
info-seekers, we are well known for discovering undervalued
companies and bringing them to the attention of the investment
community. Through our parent Company, we also have the ability to
facilitate road shows to present your products and services to the
most influential investment banks in the space.
All information contained herein as well as on
the EmergingGrowth.com website
is obtained from sources believed to be reliable but not guaranteed
to be accurate or all-inclusive. All material is for informational
purposes only, is only the opinion of EmergingGrowth.com and
should not be construed as an offer or solicitation to buy or sell
securities. The information includes certain forward-looking
statements, which may be affected by unforeseen circumstances and /
or certain risks.
This
report is not without bias. EmergingGrowth.com
has motivation by means of either self-marketing
or EmergingGrowth.com has
been compensated by or for a company or companies discussed in this
article. EmergingGrowth.com has
been compensated
twenty
thousand
three
hundred
fifty
dollars in consideration for its work with
RemSleep
Holdings, Inc. through the date this was
published. EmergingGrowth.com may
or may not receive additional compensation, details about which can
be found in our full disclosure, which can be found
here, https://emerginggrowth.com/7675-68375/.
You
can easily
lose
money investing in highly speculative small cap stocks like the
ones mentioned within. Please consult an investment professional
before investing in anything viewed within. When EmergingGrowth.com is
long shares it will sell those shares. In addition, please make
sure you read and understand the Terms of Use, Privacy Policy and
the Disclosure posted on the EmergingGrowth.com
CONTACT:
Company:
EmergingGrowth.com - http://www.EmergingGrowth.com
Contact
Email: info@EmergingGrowth.com
SOURCE:
EmergingGrowth.com